...
首页> 外文期刊>Acta oncologica. >Proton range shift analysis on brain pseudo-CT generated from T1 and T2 MR
【24h】

Proton range shift analysis on brain pseudo-CT generated from T1 and T2 MR

机译:质子范围转变分析T1和T2先生产生的脑伪CT

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In radiotherapy, MR imaging is only used because it has significantly better soft tissue contrast than CT, but it lacks electron density information needed for dose calculation. This work assesses the feasibility of using pseudo-CT (pCT) generated from T1w/T2w MR for proton treatment planning, where proton range comparisons are performed between standard CT and pCT. Material and methods: MR and CT data from 14 glioblastoma patients were used in this study. The pCT was generated by using conversion libraries obtained from tissue segmentation and anatomical regioning of the T1w/T2w MR. For each patient, a plan consisting of three 18Gy beams was designed on the pCT, for a total of 42 analyzed beams. The plan was then transferred onto the CT that represented the ground truth. Range shift (RS) between pCT and CT was computed at R80 over 10 slices. The acceptance threshold for RS was according to clinical guidelines of two institutions. A y-index test was also performed on the total dose for each patient.Results: Mean absolute error and bias for the pCT were 124+10 and -16±26 Hounsfield Units (HU), respectively. The median and interquartile range of RS was 0.5 and 1.4 mm, with highest absolute value being 4.4 mm. Of the 42 beams, 40 showed RS less than the clinical range margin. The two beams with larger RS were both in the cranio-caudal direction and had segmentation errors due to the partial volume effect, leading to misassignment of the HU.Conclusions: This study showed the feasibility of using Tiw and T2w MRI to generate a pCT for proton therapy treatment, thus avoiding the use of a planning CT and allowing better target definition and possibilities for online adaptive therapies. Further improvements of the methodology are still required to improve the conversion from MRI intensities to HUs.
机译:背景技术:在放射疗法中,仅使用MR成像,因为它具有比CT更好的软组织对比,但由于剂量计算缺乏电子密度信息。这项工作评估了使用从T1W / T2W MR产生的PSEUDO-CT(PCT)进行质子处理规划的可行性,其中质子范围比较在标准CT和PCT之间进行。材料和方法:本研究中使用了来自14名胶质母细胞瘤患者的MR和CT数据。通过使用从T1W / T2W MR的组织分割和解剖区域获得的转化文库产生PCT。对于每个患者,在PCT上设计了由三个18Gy梁组成的计划,总共42个分析的梁。然后将计划转移到代表地面真理的CT上。 PCT和CT之间的范围移位(RS)在R80上计算超过10个切片。 RS的接受阈值是根据两个机构的临床指南。还对每位患者的总剂量进行Y级指数试验。结果:PCT的平均绝对误差和偏置分别为124 + 10和-16±26 Hounsfield单元(HU)。中位数和狭窄的R级为0.5和1.4毫米,绝对值最高为4.4毫米。在42个光束中,40显示比临床范围边距小于卢比。具有较大RS的两个光束均在Cranio - 尾部方向上,并且由于部分体积效应而导致分割误差,导致Hu.conclusions的错误分配:本研究表明使用TIW和T2W MRI产生PCT的可行性质子疗法治疗,从而避免使用规划CT并允许更好的目标定义和在线自适应疗法的可能性。仍然需要进一步改进方法,以改善从MRI强度到HUS的转换。

著录项

  • 来源
    《Acta oncologica.》 |2018年第11期|共11页
  • 作者

    Giampaolo Pileggi;

  • 作者单位

    Department of Experimental and Clinical Medicine Magna Graecia University of Catanzaro Catanzaro;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号